Abivax SA
PAR:ABVX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abivax SA
PAR:ABVX
|
FR |
|
A
|
Amphenol Corp
XMUN:XPH
|
US |
|
Castor Maritime Inc
NASDAQ:CTRM
|
CY |
|
C
|
Corcept Therapeutics Inc
SWB:HTD
|
US |
|
M
|
Merck & Co Inc
F:6MK
|
US |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
F
|
Fujitsu Ltd
XMUN:FUJ1
|
JP |
|
N
|
NEC Corp
F:NEC1
|
JP |
|
B
|
Boston Scientific Corp
F:BSX
|
US |
|
G
|
Glencore PLC
XMUN:8GC
|
CH |
|
S
|
Sompo Holdings Inc
XMUN:ANK
|
JP |
|
S
|
Sompo Holdings Inc
F:ANK
|
JP |
|
E
|
Endurance RP Ltd
F:RPG
|
HK |
|
O
|
Onto Innovation Inc
XMUN:NNM
|
US |
|
P
|
Peabody Energy Corp
F:PBE
|
US |
|
H
|
Hewlett Packard Enterprise Co
F:2HP
|
US |
|
F
|
Fast Retailing Co Ltd
XMUN:FR7
|
JP |
|
A
|
Associated British Foods PLC
OTC:ASBFY
|
UK |
|
argenx SE
NASDAQ:ARGX
|
NL |
|
Gilead Sciences, Inc
MIL:1GILD
|
US |
|
Beowulf Mining PLC
LSE:BEM
|
UK |
|
NGK Spark Plug Co Ltd
F:NGK
|
JP |
|
E
|
Exor NV
DUS:EYX
|
NL |
Bankruptcy Probability
Abivax SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Abivax SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Abivax SA
PAR:ABVX
|
7.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
221.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Abivax SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Abivax SA has total debt of 554k EUR. This includes both short-term (0 EUR) and long-term (554k EUR) debt.
You can find a full breakdown on its Balance Sheet.